RHI vs RIGL · P/E 21, rev $5.38B vs P/E 9.1, rev $137.5M
Robert Half International Inc (RHI) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
Robert Half International Inc (RHI) is a staffing & employment services company listed on US.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Latest reported RHI revenue for 2025-12-31 was $5.38B. Net income was $133.0M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
Latest reported RIGL revenue for 2026-06-30 was $137.5M. Net income was $25.9M. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
RHI currently screens at market cap $4.38B and trailing P/E 21.4. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the RHI and RIGL stock pages for the full models.
Not investment advice.